<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Lilly&#8217;s Mounjaro® (tirzepatide) Approved in Hong Kong in KwikPen® Presentation for Chronic Weight Management and Type 2 Diabetes, Offering a New Option for the Treatment of Obesity, Overweight and Type 2 Diabetes	</title>
	<atom:link href="https://9krapalm.com/lillys-mounjaro-tirzepatide-approved-in-hong-kong-in-kwikpen-presentation-for-chronic-weight-management-and-type-2-diabetes-offering-a-new-option-for-the-treatment-of-obesity-overwei/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/lillys-mounjaro-tirzepatide-approved-in-hong-kong-in-kwikpen-presentation-for-chronic-weight-management-and-type-2-diabetes-offering-a-new-option-for-the-treatment-of-obesity-overwei/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Mon, 28 Oct 2024 07:49:34 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
</channel>
</rss>
